Jan 29, 2026, 01:01 AM by User Not Found

Bio-IT World | Earlier this month at the J.P. Morgan Healthcare Conference, Eli Lilly Chairman and CEO David Ricks spoke at a fireside chat and presented what the company has planned for 2026, which also marks its 150th anniversary. This year is expected to be a productive one in terms of clinical trial activity, wider availability of medicines, and expansion into new therapeutic areas.

Jan 29, 2026, 01:00 AM by User Not Found

Bio-IT World | Earlier this month at the J.P. Morgan Healthcare Conference, Eli Lilly Chairman and CEO David Ricks spoke at a fireside chat and presented what the company has planned for 2026, which also marks its 150th anniversary. This year is expected to be a productive one in terms of clinical trial activity, wider availability of medicines, and expansion into new therapeutic areas.

Jan 28, 2026, 08:44 AM by

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

Jan 28, 2026, 08:44 AM by

Jan 28, 2026, 01:01 AM by User Not Found

Bio-IT World | Parabilis Medicines will continue the clinical development of FOG-001 (zolucatetide), the company’s lead investigational Helicon peptide; Alveus Therapeutics will advance into Phase 2 clinical development of ALV-100, the company’s lead program; Soley Therapeutics plans to advance its proprietary cell stress sensing platform; and more.

Jan 27, 2026, 10:44 AM by

Jan 27, 2026, 10:44 AM by

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform.

Jan 27, 2026, 10:44 AM by

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

Jan 27, 2026, 10:44 AM by

Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations

Jan 27, 2026, 10:44 AM by

Ceryx has strengthened its Board of Directors with the appointment of Mark Strong.

Jan 27, 2026, 01:01 AM by User Not Found

Bio-IT World | BigHat Biosciences and Revvity have entered collaborations with Eli Lilly and Company; Immunai has signed an agreement with Bristol Myers Squibb; SandboxAQ launches a new AI model; and more.

Jan 26, 2026, 09:01 AM by

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

Jan 23, 2026, 10:47 AM by

Jan 23, 2026, 10:47 AM by

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

Jan 23, 2026, 01:06 AM by User Not Found

Bio-IT World | The mood at this year's J.P. Morgan Healthcare Conference signals a dramatic shift for biopharma dealmaking, with industry leaders projecting 2026 could eclipse last year's surging merger and acquisition activity. During an Endpoints News panel discussion, senior executives from AbbVie, Amgen, and Merck expressed confidence that favorable market conditions and breakthrough science are converging to create what one panelist called "a renaissance moment" for the sector.

Jan 23, 2026, 01:01 AM by User Not Found

Bio-IT World | Applying artificial intelligence (AI) to fragmented and incomplete safety data cannot fill the gap left when the right information has not been captured during initial patient adverse event reporting. And yet, software vendors position the technology as a quick fix to safety data complexity. Although AI definitely has a role to play, it would be far better to use it to refine the data capture process.

Jan 21, 2026, 08:35 AM by

Jan 21, 2026, 08:35 AM by

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

Jan 21, 2026, 08:35 AM by

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

Jan 21, 2026, 08:35 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).